Liew Kong Yen, Wang Yaju, Mullapudi Sneha Sree, Aziz Dinah Binte, Fan Wenjie, Luo Min, Tambyah Paul Anantharajah, Tan Yee-Joo
Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Infectious Diseases Translational Research Programme and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Viruses. 2025 Jun 24;17(7):886. doi: 10.3390/v17070886.
At least three betacoronaviruses have spilled over from bats to humans and caused severe diseases, highlighting the threat of zoonotic transmission. Thus, it is important to enhance surveillance capabilities by developing tools capable of detecting a broad spectrum of bat-borne betacoronaviruses. Three monoclonal antibodies (mAbs) targeting the nucleocapsid (N) protein were generated using recombinant N proteins from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The cross-reactivities of these mAbs were evaluated against a panel of betacoronaviruses. Sandwich ELISAs (sELISAs) were subsequently developed to detect bat-borne betacoronaviruses that have high zoonotic potential. Among the mAbs, 7A7 demonstrated the broadest cross-reactivity, recognizing betacoronaviruses from the , and subgenera. The first sELISA, based on mAbs 7A7 and 6G10, successfully detected N protein in all clinical swab samples from COVID-19 patients with cycle threshold (Ct) values < 25, achieving 75% positivity overall (12/16). Using this as a reference, a second sELISA was established by pairing mAb 7A7 with mAb 8E2, which binds to multiple merbecoviruses. This assay detected the N protein of two merbecoviruses, namely the human MERS-CoV and bat-borne HKU5-CoV, at high sensitivity and has a limit of detection (LOD) that is comparable to the first sELISA used successfully to detect COVID-19 infection. These broadly reactive mAbs could be further developed into rapid antigen detection kits for surveillance in high-risk populations with close contact with wild bats to facilitate the early detection of potential zoonotic spillover events.
至少三种β冠状病毒已从蝙蝠传播给人类并引发严重疾病,凸显了人畜共患病传播的威胁。因此,通过开发能够检测多种蝙蝠传播的β冠状病毒的工具来增强监测能力非常重要。利用严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和中东呼吸综合征冠状病毒(MERS-CoV)的重组核衣壳(N)蛋白制备了三种靶向核衣壳(N)蛋白的单克隆抗体(mAb)。评估了这些单克隆抗体对一组β冠状病毒的交叉反应性。随后开发了夹心酶联免疫吸附测定(sELISA)来检测具有高人畜共患病潜力的蝙蝠传播的β冠状病毒。在这些单克隆抗体中,7A7表现出最广泛的交叉反应性,可识别来自α、β和γ亚属的β冠状病毒。基于单克隆抗体7A7和6G10的第一种sELISA成功检测了所有来自COVID-19患者且循环阈值(Ct)值<25的临床拭子样本中的N蛋白,总体阳性率达到75%(12/16)。以此为参考,通过将单克隆抗体7A7与能结合多种merbecovirus的单克隆抗体8E2配对,建立了第二种sELISA。该检测方法以高灵敏度检测到了两种merbecovirus的N蛋白,即人类MERS-CoV和蝙蝠传播的HKU5-CoV,其检测限(LOD)与成功用于检测COVID-19感染的第一种sELISA相当。这些具有广泛反应性的单克隆抗体可进一步开发成快速抗原检测试剂盒,用于对与野生蝙蝠密切接触的高危人群进行监测,以促进对潜在人畜共患病溢出事件的早期检测。